Antibacterial therapy for severe sarcoid uveitis

Study of antibacterial therapy for severe uveitis by sarcoidosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031180301

Enrollment

Registered

2019-03-15

Start date

2017-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe uveitis by sarcoidosis Other eyes and adnexal disease

Interventions

Ordinary steroid medication with Clarithromycin and minomycin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Active uveitis by sarcoidosis at vitreous body or fundus

Exclusion criteria

Exclusion criteria: Systemic infectious disease

Design outcomes

Primary

Measure	Time frame
Disappearance of symptom	—

Secondary

Measure	Time frame
Occurrence of adverse events	—

Contacts

Public ContactHiroshi Takase

Tokyo Medical and Dental University Medeical hospital

h.takase.oph@tmd.ac.jp+81-3-5803-5302

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026